SCPX (Scorpius Holdings) Prakiraan wutah bathi resik saben saham kanggo taun ngarep

NightHawk Biosciences - logo grafis emiten SCPX

The 12-month expected EPS growth chart for Scorpius Holdings, Inc. (SCPX) demonstrates positive dynamics amid US protectionism and restrictions on Chinese laboratories, with the current mark equal to 0.00. Scorpius Holdings, Inc. (SCPX) maintains an impeccable image as a reliable partner in the field of clinical testing. Stable income is ensured by providing third-party firms with capacities for the development of biologics.

Scorpius Holdings Inc. (SCPX): Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep saka 21.02.2024 nganti 26.04.2025

Rincian metrik lan analitis perusahaan Scorpius Holdings Inc. (SCPX)

Pambiji fundamental perusahaan:SCPX, NightHawk Biosciences
Barang utama Scorpius Holdings

Attracting highly qualified biochemists for contract drug synthesis directly impacts the operational efficiency of Scorpius Holdings, Inc. (SCPX), which is reflected in the earnings per share (EPS) dynamics. By analyzing this EPS growth forecast, investors assess market consensus expectations regarding the company's ability to convert its technological potential into actual financial growth in the next reporting period.